<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="adverse-event-causality-res-relatedness"/>
  <meta>
    <lastUpdated value="2020-12-28T16:55:11.085+11:00"/>
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/>
  </meta>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="pc"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="draft"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/>
  </extension>
  <url value="http://hl7.org/fhir/CodeSystem/adverse-event-causality-res-relatedness"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.4.642.1.0"/>
  </identifier>
  <version value="4.6.0"/>
  <name value="AdverseEventCausalityAssessmentResearch"/>
  <title value="Adverse Event Causality Assessment for Research"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2020-12-28T16:55:11+11:00"/>
  <publisher value="HL7 (FHIR Project)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/fhir"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="fhir@lists.hl7.org"/>
    </telecom>
  </contact>
  <description value="Codes to indicate if the suspected entity caused the adverse event. Specific to Clinical Research trial reporting."/>
  <caseSensitive value="true"/>
  <valueSet value="http://hl7.org/fhir/ValueSet/adverse-event-causality-res-relatedness"/>
  <content value="complete"/>
  <concept>
    <code value="definite"/>
    <display value="Definite"/>
    <definition value="i) Event or laboratory test abnormality, with plausible time relationship to drug intake; ii) Cannot be explained by disease or other drugs; iii) Response to withdrawal plausible (pharmacologically, pathologically); iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon); or v) Re-challenge satisfactory, if necessary."/>
  </concept>
  <concept>
    <code value="probable"/>
    <display value="Probable"/>
    <definition value="i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Unlikely to be attributed to disease or other drugs; iii) Response to withdrawal clinically reasonable; or iv) Re-challenge not required."/>
  </concept>
  <concept>
    <code value="possible"/>
    <display value="Possible"/>
    <definition value="i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Could also be explained by disease or other drugs; or iii) Information on drug withdrawal may be lacking or unclear."/>
  </concept>
  <concept>
    <code value="unlikely"/>
    <display value="Unlikely"/>
    <definition value="i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible); or ii) Disease or other drugs provide plausible explanations."/>
  </concept>
  <concept>
    <code value="unrelated"/>
    <display value="Unrelated"/>
    <definition value="Suspected entity is not related to adverse event"/>
  </concept>
  <concept>
    <code value="not-receiving-treatment"/>
    <display value="Not receiving treatment"/>
    <definition value="Subject of the adverse event was not reciving treatment in report associated clinical research trial."/>
  </concept>
</CodeSystem>